<DOC>
	<DOCNO>NCT01733732</DOCNO>
	<brief_summary>The purpose study evaluate ability SYSTANE® BALANCE SYSTANE® Gel improve comfort subject dry eye .</brief_summary>
	<brief_title>SYSTANE® BALANCE Symptoms ( OSDI ) &amp; Inflammatory Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Read , sign , date Informed Consent Document ; Must use topical ocular drop approximately 24 hour prior Visit 1 ; Meet protocolspecified dry eye criterion Screening Visit ( Visit 1 ) ; Intraocular pressure ( IOP ) less equal 22 millimeter mercury ( mmHg ) eye ; Other protocoldefined inclusion criterion may apply . History evidence ocular intraocular surgery serious trauma either eye within past 6 month ; Current punctal occlusion type ( e.g. , collagen plug , silicone plug ) ; History evidence epithelial herpes simplex keratitis ( dendritic keratitis ) ; vaccinia ; active recent varicella viral disease cornea and/or conjunctiva ; chronic bacterial disease cornea and/or conjunctiva and/or eyelid ; mycobacterial infection eye ; and/or fungal disease eye ; Use concomitant topical ocular medication study period ; Currently use Restasis unwilling discontinue use 1 month prior screen entire study period ; Use systemic medication may contribute dry eye unless stable dose regimen minimum 30 day prior Visit 1 remain stable throughout study ; Uncontrolled ocular condition uveitis , glaucoma ocular condition may preclude safe administration either drop investigation ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Lipid deficiency</keyword>
	<keyword>Inflammatory marker</keyword>
</DOC>